COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,704 Articles (22,913 medRxiv, 8,791 bioRxiv)

Most recent first Previous |  Page 575: Articles 5741-5750  | Next

Study protocol: Medium throughput proteomic characterization of children with PIMS-TS, and identification of candidate diagnostic biomarkers.
Roarty, C., Mills, C., Tonry, C., Cosgrove, P., Norman-Bruce, H., Groves, H., Watson, C., Waterfield, T.
10.1101/2022.12.27.22283890 — Posted: 2022-12-28
Viral and host small RNA transcriptome analysis of SARS-CoV-1 and SARS-CoV-2-infected human cells reveals novel viral short RNAs.
Driedonks, T., Nyberg, L., Conte, A., Ma, Z., Pekosz, A., Duban, E., Sültmann, H., Turchinovich, A., Witwer, K.
10.1101/2022.12.27.522023 — Posted: 2022-12-27
The response to BTN62b2 booster doses demonstrates that serum antibodies do not predict the establishment of immune B-cell memory in common variable immune deficiencies
Piano Mortari, E., Pulvirenti, F., Marcellini, V., Terreri, S., Fernandez Salinas, A., Ferrari, S., Di Napoli, G., Guadagnolo, D., Sulco, E., Albano, C., Guercio, M., Di Cecca, S., Milito, C., Garzi, G., Pesce, A. M., Bonanni, L., Sinibaldi, M., Di Cecilia, S., Agrati, C., Quintarelli, C., Zaffina, S., Locatelli, F., Carsetti, R., Quinti, I.
10.1101/2022.12.24.22283775 — Posted: 2022-12-27
Clinical Virology and Effect of Vaccination and Monoclonal Antibodies against SARS-CoV-2 Omicron Sub variant BF.7 (BA.5.2.1.7) : A systematic review
CHENCHULA, S., Amarneni, K. C., Ghanta, M. K., R, P., Chandra, M. B., Adusumilli, M. B., Mudda, S., Chavan, M., Gupta, R., Lakhawat, B.
10.1101/2022.12.25.22283940 — Posted: 2022-12-27
Literature analysis of the efficacy of COVID-19 vaccinations
Hulsen, T.
10.1101/2022.12.24.22283835 — Posted: 2022-12-27
Study COVID-19 Severity of Patients Admitted to Emergency Room (ER) with Chest X-ray Images
Stubblefield, J., Saldivar, C., De Feria, A., Riddle, J., Shivkumar, A., Causey, J., Qualls, J., Fowler, J., Huang, X.
10.1101/2022.12.25.22283942 — Posted: 2022-12-27
A second update on mapping the human genetic architecture of COVID-19
The COVID-19 Host Genetics Initiative, , Ganna, A.
10.1101/2022.12.24.22283874 — Posted: 2022-12-27
Techniques for Developing Reliable Machine Learning Classifiers Applied to Understanding and Predicting Protein:Protein Interaction Hot Spots
Chen, J., Kuhn, L. A., Raschka, S.
10.1101/2022.12.26.521948 — Posted: 2022-12-27
Evaluation of the molecular diversity of Brazilian strains of the B.1.1 variant of SARS-CoV-2 used in vaccines
do Nascimento, I. A., da Silva, L. S., Santos, A. C. d. S., Felix, P. T.
10.1101/2022.12.23.521847 — Posted: 2022-12-27
Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants
Tamura, T., Ito, J., Uriu, K., Zahradnik, J., Kida, I., Nasser, H., Shofa, M., Oda, Y., Lytras, S., Nao, N., Itakura, Y., Deguchi, S., Suzuki, R., Wang, L., Begum, M. M., Tsuda, M., Kosugi, Y., Fujita, S., Yoshimatsu, K., Suzuki, S., Asakura, H., Nagashima, M., Sadamasu, K., Yoshimura, K., Yamamoto, Y., Nagamoto, T., Schreiber, G., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Ikeda, T., Fukuhara, T., Saito, A., Tanaka, S., Matsuno, K., Takayama, K., Sato, K.
10.1101/2022.12.27.521986 — Posted: 2022-12-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).